| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 7th January 2021 | Brian Lee Baker | 5,200 | Open or private sale | $121.57 | $632,164.00 |
| 7th January 2021 | Brian Lee Baker | 4,545 | Exercise of derivative | $5.12 | $23,270.40 |
| 7th January 2021 | Brian Lee Baker | 513 | Open or private sale | $123.02 | $63,109.26 |
| 7th January 2021 | Brian Lee Baker | 900 | Open or private sale | $120.16 | $108,144.00 |
| 7th January 2021 | Brian Lee Baker | 10,689 | Exercise of derivative | $7.43 | $79,419.27 |
| 7th January 2021 | Brian Lee Baker | 1,299 | Exercise of derivative | $3.20 | $4,156.80 |
| 7th January 2021 | Advisors Llc Orbimed | 2,000,000 | Open or private sale | $3.50 | $7,000,000.00 |
| 7th January 2021 | Brian Lee Baker | 11,905 | Exercise of derivative | $2.19 | $26,071.95 |
| 7th January 2021 | Brian Lee Baker | 2,800 | Open or private sale | $122.65 | $343,420.00 |
| 7th January 2021 | Brian Lee Baker | 21,825 | Open or private sale | $122.44 | $2,672,253.00 |
Turning Point Therapeutics
Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.
Ticker: TPTX
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1595893
Employees: 95
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
News
Turning Point Therapeutics Announces 2021 Milestone Targets
11th January 2021
Turning Point and Zai Lab Broaden Collaboration
11th January 2021
